American Shared Hospital Srvcs (AMS) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the American Shared Hospital Srvcs stock forecast from 0 analysts, the average analyst target price for American Shared Hospital Srvcs is not available over the next 12 months. American Shared Hospital Srvcs’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of American Shared Hospital Srvcs is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, American Shared Hospital Srvcs’s stock price was USD 3.12. American Shared Hospital Srvcs’s stock price has changed by +7.22% over the past week, +20.70% over the past month and +13.45% over the last year.
No recent analyst target price found for American Shared Hospital Srvcs
No recent average analyst rating found for American Shared Hospital Srvcs
Company Overview American Shared Hospital Srvcs
American Shared Hospital Services provides radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California. Address: 601 Montgomery Street, San Francisco, CA, United States, 94111-2619 Read Less
American Shared Hospital Services provides radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arte...Read More
Frequently Asked Questions About American Shared Hospital Srvcs (AMS) Stock
Stock Target Advisor's fundamental analysis for American Shared Hospital Srvcs's stock is Slightly Bearish.
Unfortunately we do not have enough data on AMS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AMS's stock to indicate what its average analyst target is.
AMS stock's Price/Earning ratio is 30.20.
Our analysis grades AMS stock's Price / Earning ratio at F. This means that AMS stock's Price/Earning ratio is above 79% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this AMS may be a overvalued for its sector.
The last closing price of AMS's stock was USD 3.12.
The most recent market capitalization for AMS is USD 0.02B.
Unfortunately we do not have enough analyst data on AMS's stock to indicate whether its price will go up or not.
Following are ETFs with the highest allocation to American Shared Hospital Srvcs's stock :
As per our most recent records American Shared Hospital Srvcs has 31 Employees.
American Shared Hospital Srvcs's registered address is Premier Park, Winsford, United Kingdom, CW7 3RT.
You can get more information about it from American Shared Hospital Srvcs's website at https://www.admedsol.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AMS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
